News and Updates

The American Diabetes Association’s Scientific Sessions is almost coming to a close! Here is Simi Ahmed, Ph.D., head of the immune therapy program at Breakthrough T1D, who highlights some of the important immune-based therapies and what they mean for the type 1 diabetes community:

There was some really exciting T1D prevention research in day #3, and also screening for type 1 diabetes risk. Here is Jessica Dunne, Ph.D., senior director of the prevention portfolio, who gives a recap of day in T1D prevention research:

We’re at the 2019 American Diabetes Association Scientific Sessions, and there’s so much to learn! Here is the recap from Breakthrough T1D‘s assistant director for science, Andy Rakeman, Ph.D.:

The ADA’s Scientific Sessions has begun! Here, in the first recap, is Sanjoy Dutta, Ph.D., who highlights beta cell replacement therapies. Happy viewing!

The American Diabetes Association’s (ADA) 79th Scientific Sessions is almost here! From June 7-11, in San Francisco, CA, scientists and healthcare professionals will gather at one of the largest conferences of diabetes researchers in the world. Breakthrough T1D researchers and Breakthrough T1D-funded scientists will also be there to hear first-hand and present new study results […]

More than 120 Young Adults joined Breakthrough T1D for a weekend of networking, learning and connecting at the Breakthrough T1D Young Adult Conference held in Dallas, Texas on March 30 and 31. Find the photos of this electrifying conference here. The conference experience was enriched by speakers who inspired our participants by talking about living […]

Join diabetes researchers from around the world at the annual Advanced Technologies & Treatments for Diabetes (ATTD) conference. Breakthrough T1D-funded research will be featured, with 23 funded researchers presenting.

At the Network for Pancreatic Organ Donors with Diabetes (nPOD) Meeting—its 11th annual and taking place February 19-22—more than 215 people are attending, including some of the most world-renowned diabetes investigators. Many of the latest advances will be discussed—using nPOD samples—to accelerate breakthroughs to cure, prevent, and treat type 1 diabetes (T1D) and its complications. […]